Eli Lilly and Co.'s GAAP net income for 3 months of 2021 was $1.355 billion, down 7% from $1.457 billion in the previous year. Revenues rose 16.1% to $6.806 billion from $5.86 billion a year earlier.
Eli Lilly and Co.'s GAAP net income for 3 months of 2021 was $1.355 billion, down 7% from $1.457 billion in the previous year. Revenues rose 16.1% to $6.806 billion from $5.86 billion a year earlier. 
investor.lilly.com
English (US) 